Penile Traction Therapy by SizeGenetics – Ireland

🔬 Does penile traction therapy actually work? The clinical evidence from over 15 peer-reviewed trials and a 2023 meta-analysis gives a clear, evidence-based answer.

🔗 Full guide: https://sizegenetics.com/en-ie/blogs/penile-traction-therapy/does-it

Show Notes

Episode Summary

Does penile traction therapy actually work? This episode walks through more than 15 peer-reviewed trials, a 2023 meta-analysis, and the biological mechanism behind documented length gains — separating clinical evidence from category hype.

Key Findings

  • Meta-Analysis (Almsaoud 2023): Weighted mean length gain of 1.9 cm across 12 pooled studies
  • Toussi 2021 RCT: 1.6 cm gain in traction group vs. 0.3 cm in controls; 87 percent would repeat therapy, 93 percent would recommend
  • Gontero et al.: Mean gain of 1.3 cm; Nikoobakht et al.: 1.7 cm in flaccid and stretched length
  • Curvature: 27 percent mean curvature improvement reported in pooled data
  • Protocol: Typical regimen is 4 to 6 hours daily over 3 to 6 months; 82 percent adherence rate
  • Safety: No serious adverse events reported; mild side effects in roughly 11 to 14 percent of users

The Science

Mechanotransduction is the cellular response to sustained mechanical force. Calibrated tension applied over time triggers tissue remodeling and true elongation — a structural change, not temporary swelling.

About SizeGenetics

FDA-registered Class II medical device, manufactured by Danamedic ApS in Denmark since 1994. Delivers calibrated tension of 900–2,800 grams — the exact therapeutic range used in clinical studies. Over 1 million units sold worldwide.

Resources

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before starting any treatment.

What is Penile Traction Therapy by SizeGenetics – Ireland?

SizeGenetics — Science-first education about FDA-registered traction therapy from the inventors of the category (1994). Clinically proven. Over 1,000,000 devices sold worldwide.

We're the official YouTube channel for SizeGenetics, an FDA-registered Class II medical device developed by Danamedic ApS in Denmark. Danamedic didn't just make a penile traction device — they invented penile traction therapy itself in 1994. That's 32 years of clinical engineering, over 1,000,000 devices sold, and a body of evidence spanning 15+ peer-reviewed studies.

SizeGenetics was co-invented by Dr. Jorn Ege Siana, a plastic surgeon, alongside medical advisors Dr. Finn Worm Knudsen and Dr. Michael Carter. The device delivers calibrated traction of up to 3,200 grams using the same tissue expansion science that surgeons have relied on for decades in reconstructive medicine.

If you've ever wondered whether penile traction therapy is real medicine or just another overhyped promise, the clinical evidence gives a surprisingly clear answer. This is one of the few non-surgical approaches in men’s sexual health that has been studied across more than fifteen peer-reviewed trials involving over 1,000 patients, and the findings keep pointing in the same direction: penile traction therapy can produce measurable length gains when it’s used correctly and consistently.

So what does “works” actually mean here? In clinical terms, it means documented structural change, not a temporary effect and not wishful thinking. Across published studies, penile traction therapy has produced average length gains in the range of 1.3 to 2.3 centimeters, or about half an inch to just under an inch, over three to six months of daily use. The strongest summary of that evidence came in 2023, when Almsaoud, Safar, and Alshahrani published a systematic review and meta-analysis in Translational Andrology and Urology. Looking across twelve pooled studies, they calculated a weighted mean length gain of 1.9 centimeters. That matters, because meta-analyses sit at the top of the evidence hierarchy.

And it’s not just pooled data. Individual clinical trials tell the same story. In a randomized controlled trial published by Toussi and colleagues in 2021, men in the traction group gained 1.6 centimeters compared with just 0.3 centimeters in the control group. That difference was statistically significant, which is exactly what you want to see when asking whether a device is doing the work or whether the result could just be random variation. Even more encouraging, 87 percent of participants said they would repeat the therapy, and 93 percent said they would recommend it.

Earlier studies support that same pattern. Gontero and colleagues reported a mean gain of 1.3 centimeters. Nikoobakht and colleagues found a 1.7 centimeter gain in both flaccid and stretched length measurements. In Peyronie’s disease research, Levine and colleagues showed that traction therapy could help reduce curvature while preserving length. And in the broader 2023 meta-analysis, the data also showed a 27 percent mean curvature improvement and an 82 percent adherence rate, suggesting that most men were able to stay with the treatment long enough to see meaningful outcomes.

Now, none of this means penile traction therapy is magic. The results depend heavily on protocol and adherence. Most of the evidence is based on daily wear of about four to six hours per day over three to six months. That’s a real commitment. If someone uses a device inconsistently, cuts the wear time in half, or quits after a few weeks, the clinical evidence doesn’t support expecting the same outcomes. This is more like physical therapy than a quick fix. Consistency is the treatment.

The biological reason traction can work is mechanotransduction, the cellular response to mechanical force. When calibrated tension is applied to tissue over time, cells respond by remodeling and generating structural change. In plain language, the body adapts to sustained mechanical loading. That’s why researchers describe these gains as tissue elongation, not temporary swelling. It’s also why traction therapy is fundamentally different from pumps, pills, or manual exercises. Pumps can create short-term engorgement, but that effect fades. Supplements have not produced permanent length gains in randomized trials. Traction therapy is the method with the clinical record behind it.

Safety matters too, especially in a category filled with exaggerated claims. Across the published literature, no serious adverse events have been reported. Mild and temporary side effects, things like minor discomfort or skin irritation, show up in roughly 11.2 to 14.4 percent of participants. That doesn’t mean zero risk, but it does suggest a favorable safety profile when medically designed devices are used correctly.

And that brings us to device quality. SizeGenetics is part of the original Danamedic lineage from Denmark, the company behind the modern traction category since 1994. Danamedic was founded in 1988, and Dr. Jørn Ege Siana, a plastic surgeon and co-inventor, helped establish the traction mechanism that shaped the category. Devices in this lineage are FDA-registered medical devices, and that regulatory distinction matters because proper traction therapy depends on calibrated, controlled force, not improvised stretching.

So, does penile traction therapy really work? Based on the current clinical evidence, yes, for length gains, and in some cases curvature improvement, provided the device is legitimate and the protocol is followed. The honest expectation is not overnight transformation. It’s measurable progress, backed by studies, over months of disciplined use. If you’re evaluating your options, that’s the takeaway to hold onto: ignore the hype, follow the evidence, and choose a medically grounded traction device with a real clinical pedigree.